Pimecrolimus and tacrolimus for the treatment of intertriginous and facial psoriasis: are they effective?

Affiliations

¹ Department of Dermatology, Harvard Medical School and Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02115, USA. mbigby@bidmc.harvard.edu

Comment

Michael Bigby. Arch Dermatol. 2005 Sep.

. 2005 Sep;141(9):1152-3.

doi: 10.1001/archderm.141.9.1152.

¹ Department of Dermatology, Harvard Medical School and Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02115, USA. mbigby@bidmc.harvard.edu

No abstract available

Comment in

Proven efficacy of tacrolimus for facial and intertriginous psoriasis.
Lebwohl M, Freeman A, Chapman MS, Feldman S, Hartle J, Henning A. Lebwohl M, et al. Arch Dermatol. 2005 Sep;141(9):1154. doi: 10.1001/archderm.141.9.1154. Arch Dermatol. 2005. PMID: 16172314 No abstract available.

Tacrolimus ointment is effective for facial and intertriginous psoriasis.
Lebwohl M, Freeman AK, Chapman MS, Feldman SR, Hartle JE, Henning A; Tacrolimus Ointment Study Group. Lebwohl M, et al. J Am Acad Dermatol. 2004 Nov;51(5):723-30. doi: 10.1016/j.jaad.2004.07.011. J Am Acad Dermatol. 2004. PMID: 15523350 Clinical Trial.
Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study.
Gribetz C, Ling M, Lebwohl M, Pariser D, Draelos Z, Gottlieb AB, Zaias N, Chen DM, Parneix-Spake A, Hultsch T, Menter A. Gribetz C, et al. J Am Acad Dermatol. 2004 Nov;51(5):731-8. doi: 10.1016/j.jaad.2004.06.010. J Am Acad Dermatol. 2004. PMID: 15523351 Clinical Trial.